Factor VIII 500IU

Factor VIII 500IU


Project Description

Active Ingredient: 8Y 500IU/20mL

Dosage Form: Powder for solution for injection

Indication:

  • Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).
  • Prevention and treatment of haemorrhage or surgical bleeding in von Willebrand disease (VWD), when desmopressin (DDAVP) treatment alone is ineffective or contra-indicated.

Packaging: Box of 1 Powder  + 20 mL vial of sterilised water + 1 syringe

Manufacturer: Bio Products Laboratory Limited – UK